Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page
- Check7 days agoChange Detected- The Locations section has been expanded and reorganized to include many new site entries across the US, Canada, Europe, Australia, and other regions, with granular, region-specific listings replacing broad location categories.SummaryDifference2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe Publications section description now states that entries are automatically filled from PubMed, replacing the previous wording. The revision number was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedTaiwan study locations were updated: two new entries for Tainan, Taiwan 701 and 704 were added, and the corresponding Tainan City, Taiwan 701 and 704 entries were removed.SummaryDifference0.1%

- Check57 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page for NCT02580058. The content remains focused on trial design, eligibility, interventions, and outcomes.SummaryDifference0.1%

- Check86 days agoChange DetectedCore content updated with government funding status and operating details; version bumped to v3.2.0. Deletion of a specific resource listing (Genetic and Rare Diseases Information Center resources: Ovarian cancer) and removal of the older revision tag (v3.0.2).SummaryDifference1%

- Check101 days agoChange DetectedRemoved a 'Back to Top' link; no significant content or data changes.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.